Skip to main content

TearLab Corporation Value Stock - Dividend - Research Selection

TearLab Corporation

ISIN: US8781932004, WKN: A2DMKX

Market price date: 30.11.-0001
Market price: 0,00 USD




TearLab Corporation Fundamental data and company key figures of the share

Annual reports in USD
Key figures 15-03-2020
Cash flow
Net operating cash flow -954.000
Capital Expenditures -411.000
Free cash flow -1.365.000
Balance sheet
Total Equity -26.021.000
Liabilities & Shareholders equity 14.293.000
Income statement
Net income -5.416.000
Eps (diluted) -0,440
Diluted shares outstanding 12.309.100
Net sales/revenue 22.655.000

Fundamental ratios calculated on: 30-11--0001

Ratios
Key figures 30-11--0001
Cash flow
P/C 0,00
   
P/FC 0,00
Balance sheet
ROI0,00
ROE0,00
Income statement
P/E0,00
Div. Yield0,00%
P/B0,00
P/S0,00


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolTEAR
Market Capitalization738.546,00 USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internetwww.tearlab.com


Description of the company

TearLab Corp. is an in-vitro diagnostic company. The Company is commercializing a tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company´s first product measures tear film osmolarity for the diagnosis of Dry Eye Disease (DED). TearLab Research, Inc., its wholly owned subsidiary, develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites (i.e. glucose), genes and proteins) at the point-of-care. Commercializing that tear testing platform is the focus of the Company´s business. Its TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor´s office. The TearLab Osmolarity System consists of three components: the TearLab disposable, the TearLab Pen and the TearLab Reader.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.tearlab.com